[1] The consequences of untreated deficiency far outweigh the inconvenience of mild, manageable gastrointestinal symptoms
[2] [3] The most frequently documented adverse effects of tirzepatide include gastrointestinal symptoms such as nausea, vomiting, diarrhoea, and decreased appetite, which occur in a significant proportion of patients, particularly during dose escalation
Some patients are unable to break down the protein to absorb vitamin B12 into the bloodstream while others are at risk for low levels of B12 because the food consumed doesnt contain high enough amounts of B12, such as vegetarians or vegans
Glucagon-Like Peptide 1 Receptor Agonists and 13 Obesity-Associated Cancers in Patients With Type 2 Diabetes
An ongoing clinical trial (NCT06939088) is currently studying the effects of tirzepatide specifically on alcohol intake, with results expected in the coming years